EUR-1008 25,000 Units
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
Forest Laboratories
Overview
EUR-1008 25,000 Units is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
EUR-1008 25,000 Units clinical trials
Explore related
Medical disclaimer. This page summarizes research about EUR-1008 25,000 Units for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.